Media Corner

The GvHD Alliance is proud to announce its expansion into Europe — a significant milestone in its mission to improve the lives of people affected by Graft-versus-Host Disease (GvHD).

The EBMT, the EHA, and the GoCART Coalition proudly announce the release of the second edition of the EU CAR-T Handbook, a comprehensive, open-access resource covering the latest developments in CAR-T cell therapies.

A new machine learning model developed by the EBMT significantly improves the assessment of transplant risks in patients with myelofibrosis.

The EBMT is proud to announce that its Registry has achieved a landmark milestone of 10,000 chimeric antigen receptor T-cell (CAR-T) therapy patients.

The EBMT proudly commemorates its 50th anniversary, marking five decades of transformative advancements in the field of hematopoietic cell transplantation (HCT) and cellular therapy.

An international team started the research project CERTAINTY in December 2023.